Skip to content
Showing 1 - 10 of 127 results.
Columbia University incoming president Nemat “Minouche” Shafik, PhD, visited Columbia University Irving Medical Center.
The efficacy of the bivalent boosters.
The updated COVID-19 vaccine boosters don’t appear to provide any better protection than the original shot does.
the U.S. may face another wave of hospitalizations from the disease this winter.
Omicron descendants, BQs – BQ.1, BQ.1.1, and XBB.1.5, are spreading fast in the US.
The BQ.1, BQ.1.1, XBB and XBB.1 omicron subvariants are the most immune evasive variants of Covid-19 to date.
New studies are fueling debate about whether the booster shot targeting the BA.4 and BA.5 versions of omicron is superior to another shot of the original.
Researchers at Columbia and Harvard compared how the immune systems of volunteers responded to the new bivalent boosters versus the original vaccine.
Results show the new shots perform similarly to past ones. Moderna, Pfizer boosters aim to protect against new variants
Controversy surrounding a study that involved modifying the SARS-CoV-2 virus has prompted researchers to call for better guidance from funders.
